Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • In Vitro and In Vivo Neutraliz...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients

Bibliographic Details
Main Authors: Ilies Benotmane, Martin Jungbauer-Groznica, Isabelle Staropoli, Delphine Planas, Océane Dehan, Angela Brisebarre, Etienne Simon-Loriere, Samira Fafi-Kremer, Olivier Schwartz, Timothée Bruel, Sophie Caillard
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Series:Transplant International
Subjects:
sotrovimab
COVID-19
immunocompromised
kidney transplant recipients
monoclonal antibodies
SARS-CoV-2
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13272/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13272/full

Similar Items

  • Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
    by: Floriane Gallais, et al.
    Published: (2022-02-01)
  • HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
    by: Jérémy Dufloo, et al.
    Published: (2018-07-01)
  • Aichivirus A1 replicates in human intestinal epithelium and bronchial tissue: Lung–gut axis?
    by: Martin Jungbauer-Groznica, et al.
    Published: (2024-04-01)
  • Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model
    by: Cécile Hérate, et al.
    Published: (2023-06-01)
  • Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
    by: Delphine Planas, et al.
    Published: (2024-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs